(Q58043487)
Statements
Decrease of interleukin 6 during the first 12 months is a prognostic marker for clinical outcome during 36 months treatment with disease-modifying anti-rheumatic drugs (English)
T Lichtinger
J Schölmerich
H Menninger
B Lang
1 December 1997